Similar to SCLC patient tissues, H446 and H526 cells have relatively high expression of IGF-1R (Fig 2a), and CP treatment could inhibit the proliferation of H446 and H526 cells in both serum-added and serum-free conditions (Fig 2b). Here, IGF1R is linked to small cell lung carcinoma.